A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.


Updates from The Motley Fool

Latest updates on Dendreon Corp from Fool.com.  The Fool has written over 500 articles on Dendreon Corp.


Stock Performance

View Interactive DNDNQ Charts
Sponsored by

Key Data Points

Primary metrics and data points about Dendreon Corp.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Dendreon Corp.
CAPS Rating 1 out of 5
 
1181 Outperform
256 Underperform
CAPS All Stars
 
123 Outperform
58 Underperform

How do you think Dendreon Corp will perform against the market?



You pick for Dendreon Corp is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Dendreon Corp.

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

  • Exchange: NASDAQOTH
  • Sector: Healthcare
  • Industry: Drug Makers